iRadimed (IRMD) stock
Pro members see every stock ranked and every check behind each score, live.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live. So can you, free, with no account.
Why IRMD scores 3
Below AverageTrending down, 2 of 14 checks firingWhat the Quality Score means
- +2Chart checks 2 of 14 firing right now, one point each
- −1Long-term trend below a falling 200-day average
- Profit adds
- Growth adds
What's next
Expected to report Tue Nov 3, before the open
After its last 4 reports it closed +5.8% on average, higher 3 of 4 times.
What would turn IRMD's score around: 6 things, for Pro members
Here is what Pro members see.
See it live, free until Tuesday morning. No account. No card. Then keep going with a free account. Every stock ranked for you.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
IRMD has 2 of 14 checks firing
One per group is shown here.
Also on the chart
- RSI 1448.7
- MACD (12, 26, 9)Above signal
- 50-day average$87.39
- 200-day average$93.66
- ADX 1423.4
- Support$85.00
- Resistance$87.26
- Bollinger Bands (20, 2)Inside
- Volume0.8x
How IRMD ranks in Medical Devices
IRMD is #51 of 84 by Quality Score. The top three are shown with their scores, and more by name.
BLFS6/1418
DXCM4/1415
HTFL6/1414
INGNOpen for its score
INSPOpen for its score
IRTCOpen for its score
ISRGOpen for its score
IRMD2/143
When does IRMD report earnings, and what happens after?
Expected to report Tue Nov 3, before the open (in 30 days). Not yet confirmed by the company.
| Reported | When | Gap | Reaction | 5 sessions |
|---|---|---|---|---|
| Aug 18, 2026No time given | No time given | +0.4% | -0.2% | +0.4% |
| May 1, 2026Before open | Before open | -2.7% | +4.5% | +4.0% |
| Feb 10, 2026Before open | Before open | +3.5% | +9.6% | +4.8% |
| Nov 3, 2025Before open | Before open | +7.1% | +9.5% | +9.8% |
Who is trading IRMD
IRMD insider trades
One insider sold $123K across 2 filings in the last 6 months. No open-market buys on record. The newest:
About iRadimed
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
Pro members see every line of every stock's score.
- Real-time prices, no delay
- Every line of IRMD's score, with the points and the reason
- All 14 checks on IRMD and on all 3,243 stocks
- Every stock ranked, with the chart
- Every filing, and optional alerts on IRMD
Straight Answers
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Where does the data come from?
Daily bars, quotes, reference data, headlines, and short interest come from Massive, formerly Polygon, a licensed market data vendor. The age of the quotes is shown at the top of every page. Insider trades, notable holders and profits come straight from the SEC. That means Form 4 filings, 13F filings and XBRL financial data on EDGAR. Government filings come from the public STOCK Act and Office of Government Ethics disclosures. The market-wide headlines on the market line also come from the public headline feeds CNBC, MarketWatch and Yahoo Finance publish, shown as the headline, the source and a link to the article. Splits, dividends, and the financial statements on each ticker page come from the vendor's reference data. The 8-K filings on EDGAR are read for the items that move a price. Five years of history is loaded for every stock. So the 200-day and 52-week checks rest on real history. Options flow is not part of the product.
Do I need an account?
Not to start. Tap any green button and you're in, free, with no email and no password. To keep going, create a free account with Google, Apple, or your email. There is no password to make up.
Is this investment advice?
No. It is a screening tool that scores stocks on the chart, the company's own results, and the news and filings. It does not know your situation and it is not a recommendation to buy or sell anything. Please do your own research.